10q10k10q10k.net
GeneDx Holdings Corp.

GeneDx Holdings Corp.WGSEarnings & Financial Report

Nasdaq · Health Care · Services-Health Services

GeneDx is a genetic testing company that was founded in 2000 by two scientists from the National Institutes of Health (NIH), Sherri Bale and John Compton. They started the company to provide clinical diagnostic services for patients and families with rare and ultra-rare disorders, for which no such commercial testing was available at the time. The company started in the Technology Development Center, a biotech incubator supported by the state of Maryland and Montgomery County, MD. In 2006, Bi...

Top Holders

Holder% OwnedSharesChangeAs of
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI9.90%
2.7M
▼ -0.50pp2024-11-19
THE GOLDMAN SACHS GROUP, INC.5.00%
1.3M
▼ -2.00pp2024-11-08
OPKO Health, Inc.4.99%
1.4M
▼ -1.37pp2024-11-20
OF ABOVE PERSONS2.39%
610.8K
—2023-06-09
NOS. OF ABOVE PERSONS2.10%
537.3K
—2024-05-31
CMLS HOLDINGS LLC2.10%
537.3K
—2023-11-17

Insider Transactions

Net 90d: +$4.39M · buys $13.46M / sells $9.07M
Range:
Action:
Role:
InsiderRoleAction
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICEROption exercise
16.3K
$0.00$0
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICERSell (open market)
2.5K
$61.29$152.3K
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICERSell (open market)
961
$62.33$59.9K
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICERSell (open market)
2.5K
$63.28$159.5K
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICERSell (open market)
995
$64.60$64.3K
2026-03-26Kevin FeeleyCHIEF FINANCIAL OFFICERSell (open market)
1.9K
$65.21$121.1K
2026-03-26Katherine StuelandCHIEF EXECUTIVE OFFICEROption exercise
80.0K
$0.00$0
2026-03-26Katherine StuelandCHIEF EXECUTIVE OFFICERSell (open market)
13.2K
$61.29$810.8K
2026-03-26Katherine StuelandCHIEF EXECUTIVE OFFICERSell (open market)
5.1K
$62.33$319.0K
2026-03-26Katherine StuelandCHIEF EXECUTIVE OFFICERSell (open market)
13.4K
$63.28$848.7K
1–10 of 61
Page 1 / 7